Novo Integrated Sciences Share Holder Equity 2012-2024 | NVOS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Novo Integrated Sciences share holder equity from 2012 to 2024. Share holder equity can be defined as the sum of preferred and common equity items

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Novo Integrated Sciences share holder equity from 2012 to 2024. Share holder equity can be defined as the sum of preferred and common equity items

Related Stocks
Company Name	Market Cap
Fresenius SE (FSNUY)	$20.4B
Quest Diagnostics (DGX)	$17.8B
DaVita (DVA)	$12.3B
Encompass Health (EHC)	$10.4B
Chemed (CHE)	$8.4B
Elanco Animal Health (ELAN)	$7B
RadNet (RDNT)	$5.4B
Option Care Health (OPCH)	$3.8B
Amedisys (AMED)	$3.2B
LifeStance Health (LFST)	$2.8B
Addus HomeCare (ADUS)	$2.3B
Astrana Health (ASTH)	$2.3B
U.S Physical Therapy (USPH)	$1.4B
Pennant (PNTG)	$1.1B
Aveanna Healthcare Holdings (AVAH)	$1.1B
Atai Life Sciences (ATAI)	$237M
Daxor (DXR)	$46M
MEDIROM Healthcare Technologies (MRM)	$14M
Psychemedics (PMD)	$14M
ATI Physical Therapy (ATIP)	$11M
Ontrak (OTRK)	$8M
IMAC Holdings (BACK)	$1M